Go to Special Sales HBG USA Home Special Sales HBG USA

Ending Parkinson's Disease

A Prescription for Action

Ending Parkinson's Disease Open the full-size image

Contributors

By Ray Dorsey, MD

By Todd Sherer, PhD

By Michael S. Okun, MD

By Bastiaan R. Bloem, MD, PhD

Also available from:

On Sale
Mar 16, 2021
Page Count
352 pages
Publisher
PublicAffairs
ISBN-13
9781541724501

In this “must-read” guide (Lonnie Ali), four leading doctors and advocates offer a bold action plan to prevent, care for, and treat Parkinson’s disease-one of the great health challenges of our time.

Brain diseases are now the world’s leading source of disability. The fastest growing of these is Parkinson’s: the number of impacted patients has doubled to more than six million over the last twenty-five years and is projected to double again by 2040. Harmful pesticides that increase the risk of Parkinson’s continue to proliferate, many people remain undiagnosed and untreated, research funding stagnates, and the most effective treatment is now a half century old.

In Ending Parkinson’s Disease, four top experts provide a plan to help prevent Parkinson’s, improve care and treatment, and end the silence associated with this devastating disease.

Genre:

  • "This book offers a clear pathway forward - while sounding out a resounding clarion alarm; prompting action - that we should all pay heed to!"
    Davis Phinney, Founder, Davis Phinney Foundation for Parkinson's
  • "This book is a must-read for all of us who are or might be affected. It pulls no punches with regard to the seriousness of this emerging pandemic, and its common-sense environmental approaches and precautions, if implemented, will abate the spread of this insidious disease. I know this to be true. I lived it."
    Lonnie Ali
  • "This book shines a light on the environmental factors that put us all at risk for the disease. As a person with Parkinson's and as a father, I hope we will take the urgent action outlined in this important book to stop the growing number of people who will receive a diagnosis."
    Brian Grant, former NBA player and Founder of the Brian Grant Foundation
  • "This book shines an essential spotlight on the need to end Parkinson's, illuminating the key issues we are all facing. It is the role of everyone in the Parkinson's community, patients, researchers, clinicians and advocates, to share this book and ensure that the authors' voices are heard."
    Helen Matthews, Deputy CEO, The Cure Parkinson's Trust
  • "This book is full of practical tips to help you live well with Parkinson's disease. It's a prescription for action and shines a spotlight on what we can do as a nation to raise awareness of this disease."
    John L. Lehr, CEO and President of the Parkinson's Foundation

Formats and Prices

Price

$19.99

Price

$25.99 CAD

Format

Format:

  1. Trade Paperback $19.99 $25.99 CAD
  2. ebook $13.99 $17.99 CAD
  3. Audiobook Download (Unabridged)

You May Also Like

100 Days to a Younger Brain
100 Days to a Younger Brain $17.99 $22.99 CAD
The Grain Brain Whole Life Plan
The Grain Brain Whole Life Plan $28.00 $36.50 CAD
Brain Maker
Brain Maker $29.00 $37.00 CAD
The First Year: Multiple Sclerosis
The First Year: Multiple Sclerosis $21.99 $28.99 CAD
The TIGER Protocol
The TIGER Protocol $21.99 $28.99 CAD

Ray Dorsey, MD

About the Author

Ray Dorsey is the David M. Levy Professor of Neurology at the University of Rochester, where he directs the Center for Health + Technology. For the past decade, he has pioneered technology to care for individuals with and measure the features of Parkinson disease. His research has been published in the leading neurology, medical, and economic journals and been featured on NPR and in The Wall Street Journal, and The New York Times. Previously, Ray directed the Parkinson disease division at Johns Hopkins Medicine and consulted for McKinsey & Company.

Learn more about this author

Todd Sherer, PhD

About the Author

Todd Sherer, PhD, is the Chief Executive Officer of The Michael J. Fox Foundation for Parkinson’s Research, the largest nonprofit funder of Parkinson’s research. Trained as a neuroscientist, he is responsible for the Foundation’s overall scientific and fundraising direction to speed treatment breakthroughs and a cure for Parkinson’s disease. After a postdoctoral fellowship at Emory University investigating the role of environmental factors in Parkinson’s, Todd joined the Foundation’s staff in 2004 and was named Chief Executive Officer in 2011.

Learn more about this author